Skip to content
Awesome – Lifestyle
Author:
Zymeworks Inc.
Zymeworks Provides Corporate Update and Reports Second Quarter 2026 Financial Results
August 6, 2026
Zymeworks to Report Second Quarter 2026 Financial Results on August 6, 2026
July 16, 2026
Zymeworks to Acquire Theravance Biopharma, Inc.
June 29, 2026
Zymeworks Announces Participation in Upcoming Investor Conferences
May 13, 2026
Zymeworks Announces Additional Leadership Appointments to Advance Next Phase of Growth
April 9, 2026
Zymeworks Appoints Kristin Stafford as Chief Financial Officer
April 1, 2026
Zymeworks Receives U.S. FDA Fast Track Designation for ZW191, an FRα-Targeting Antibody-Drug Conjugate
March 30, 2026
Zymeworks Announces Presentations for Ziihera® (zanidatamab-hrii) at 2026 AACR Annual Meeting
March 18, 2026
Zymeworks to Present Clinical and Preclinical Data on ADC Programs Including Novel RAS ADC Platform at AACR Annual Meeting
March 18, 2026